annual EBITDA:
$1.37B+$142.45M(+11.62%)Summary
- As of today (May 21, 2025), JAZZ annual EBITDA is $1.37 billion, with the most recent change of +$142.45 million (+11.62%) on December 31, 2024.
- During the last 3 years, JAZZ annual EBITDA has risen by +$650.10 million (+90.49%).
- JAZZ annual EBITDA is now at all-time high.
Performance
JAZZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$98.34M-$254.55M(-72.13%)Summary
- As of today (May 21, 2025), JAZZ quarterly EBITDA is $98.34 million, with the most recent change of -$254.55 million (-72.13%) on March 1, 2025.
- Over the past year, JAZZ quarterly EBITDA has dropped by -$129.55 million (-56.85%).
- JAZZ quarterly EBITDA is now -76.85% below its all-time high of $424.74 million, reached on September 30, 2024.
Performance
JAZZ quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.24B-$129.55M(-9.47%)Summary
- As of today (May 21, 2025), JAZZ TTM EBITDA is $1.24 billion, with the most recent change of -$129.55 million (-9.47%) on March 1, 2025.
- Over the past year, JAZZ TTM EBITDA has increased by +$71.61 million (+6.13%).
- JAZZ TTM EBITDA is now -9.47% below its all-time high of $1.37 billion, reached on December 31, 2024.
Performance
JAZZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
JAZZ EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.6% | -56.9% | +6.1% |
| 3 y3 years | +90.5% | -61.7% | +67.6% |
| 5 y5 years | +52.6% | +179.7% | +113.7% |
JAZZ EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.1% | -76.8% | +181.2% | -9.5% | +127.4% |
| 5 y | 5-year | at high | +151.1% | -76.8% | +179.7% | -9.5% | +127.4% |
| alltime | all time | at high | +1167.0% | -76.8% | +179.7% | -9.5% | +775.5% |
JAZZ EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $98.34M(-72.1%) | $1.24B(-9.5%) |
| Dec 2024 | $1.37B(+11.6%) | $352.89M(-16.9%) | $1.37B(+4.7%) |
| Sep 2024 | - | $424.74M(+17.0%) | $1.31B(+7.5%) |
| Jun 2024 | - | $362.99M(+59.3%) | $1.22B(+4.1%) |
| Mar 2024 | - | $227.90M(-21.7%) | $1.17B(-4.8%) |
| Dec 2023 | $1.23B(+125.0%) | $291.05M(-12.7%) | $1.23B(+50.6%) |
| Sep 2023 | - | $333.57M(+6.0%) | $813.88M(+25.4%) |
| Jun 2023 | - | $314.83M(+9.8%) | $649.24M(+12.9%) |
| Mar 2023 | - | $286.61M(-336.6%) | $574.82M(+5.5%) |
| Dec 2022 | $544.93M(-24.1%) | -$121.14M(-171.7%) | $544.93M(-37.7%) |
| Sep 2022 | - | $168.94M(-29.7%) | $874.45M(-2.7%) |
| Jun 2022 | - | $240.41M(-6.4%) | $898.83M(+21.6%) |
| Mar 2022 | - | $256.72M(+23.2%) | $739.10M(+2.9%) |
| Dec 2021 | $718.41M(+10.0%) | $208.39M(+7.8%) | $718.41M(-4.7%) |
| Sep 2021 | - | $193.31M(+139.6%) | $754.07M(-8.9%) |
| Jun 2021 | - | $80.67M(-65.8%) | $827.82M(-18.2%) |
| Mar 2021 | - | $236.03M(-3.3%) | $1.01B(+55.0%) |
| Dec 2020 | $653.05M(-27.2%) | $244.05M(-8.6%) | $653.05M(+1.1%) |
| Sep 2020 | - | $267.06M(+0.6%) | $645.96M(+11.8%) |
| Jun 2020 | - | $265.38M(-315.0%) | $577.83M(-0.3%) |
| Mar 2020 | - | -$123.43M(-152.1%) | $579.73M(-35.3%) |
| Dec 2019 | $896.72M(+8.7%) | $236.96M(+19.1%) | $896.72M(+0.2%) |
| Sep 2019 | - | $198.92M(-25.6%) | $894.96M(-4.3%) |
| Jun 2019 | - | $267.28M(+38.1%) | $934.95M(+6.8%) |
| Mar 2019 | - | $193.56M(-17.7%) | $875.44M(+6.2%) |
| Dec 2018 | $824.69M(+20.6%) | $235.20M(-1.6%) | $824.69M(+4.8%) |
| Sep 2018 | - | $238.92M(+15.0%) | $786.55M(+15.3%) |
| Jun 2018 | - | $207.77M(+45.5%) | $682.24M(+2.8%) |
| Mar 2018 | - | $142.81M(-27.5%) | $663.36M(-3.0%) |
| Dec 2017 | $684.03M(-3.4%) | $197.05M(+46.4%) | $684.03M(-0.5%) |
| Sep 2017 | - | $134.61M(-28.7%) | $687.20M(-4.2%) |
| Jun 2017 | - | $188.90M(+15.6%) | $717.03M(-1.3%) |
| Mar 2017 | - | $163.47M(-18.4%) | $726.13M(+2.5%) |
| Dec 2016 | $708.17M(+17.9%) | $200.23M(+21.8%) | $708.17M(+10.1%) |
| Sep 2016 | - | $164.44M(-16.9%) | $643.10M(+0.8%) |
| Jun 2016 | - | $197.99M(+36.1%) | $637.89M(+6.2%) |
| Mar 2016 | - | $145.51M(+7.7%) | $600.50M(-0.1%) |
| Dec 2015 | $600.91M | $135.16M(-15.1%) | $600.91M(-4.9%) |
| Sep 2015 | - | $159.23M(-0.9%) | $631.71M(+10.9%) |
| Jun 2015 | - | $160.60M(+10.1%) | $569.49M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $145.91M(-12.1%) | $517.91M(+53.2%) |
| Dec 2014 | $337.95M(-18.9%) | $165.96M(+71.1%) | $337.95M(+17.7%) |
| Sep 2014 | - | $97.02M(-11.0%) | $287.03M(-7.5%) |
| Jun 2014 | - | $109.02M(-420.2%) | $310.42M(+5.5%) |
| Mar 2014 | - | -$34.05M(-129.6%) | $294.32M(-29.4%) |
| Dec 2013 | $416.96M(+55.3%) | $115.04M(-4.5%) | $416.96M(+7.1%) |
| Sep 2013 | - | $120.41M(+29.6%) | $389.46M(+12.8%) |
| Jun 2013 | - | $92.93M(+4.9%) | $345.38M(+12.3%) |
| Mar 2013 | - | $88.59M(+1.2%) | $307.62M(+14.6%) |
| Dec 2012 | $268.45M(+99.7%) | $87.54M(+14.7%) | $268.47M(+21.8%) |
| Sep 2012 | - | $76.33M(+38.4%) | $220.42M(+23.4%) |
| Jun 2012 | - | $55.17M(+11.6%) | $178.64M(+12.2%) |
| Mar 2012 | - | $49.44M(+25.2%) | $159.28M(+18.5%) |
| Dec 2011 | $134.41M(+147.9%) | $39.49M(+14.3%) | $134.41M(+22.0%) |
| Sep 2011 | - | $34.55M(-3.5%) | $110.21M(+19.6%) |
| Jun 2011 | - | $35.81M(+45.7%) | $92.15M(+33.2%) |
| Mar 2011 | - | $24.57M(+60.8%) | $69.20M(+27.6%) |
| Dec 2010 | $54.21M(+116.6%) | $15.28M(-7.3%) | $54.21M(+2.8%) |
| Sep 2010 | - | $16.49M(+28.4%) | $52.72M(+24.5%) |
| Jun 2010 | - | $12.85M(+34.0%) | $42.36M(+6.6%) |
| Mar 2010 | - | $9.59M(-30.5%) | $39.73M(+58.8%) |
| Dec 2009 | $25.03M(-119.9%) | $13.79M(+125.0%) | $25.03M(-462.2%) |
| Sep 2009 | - | $6.13M(-40.0%) | -$6.91M(-81.2%) |
| Jun 2009 | - | $10.22M(-299.7%) | -$36.69M(-59.0%) |
| Mar 2009 | - | -$5.12M(-71.8%) | -$89.53M(-28.7%) |
| Dec 2008 | -$125.58M(-2.1%) | -$18.14M(-23.3%) | -$125.58M(-23.2%) |
| Sep 2008 | - | -$23.65M(-44.5%) | -$163.51M(+5.5%) |
| Jun 2008 | - | -$42.62M(+3.5%) | -$155.04M(+1.6%) |
| Mar 2008 | - | -$41.16M(-26.6%) | -$152.56M(+19.0%) |
| Dec 2007 | -$128.25M(+89.3%) | -$56.08M(+269.5%) | -$128.25M(-30.1%) |
| Sep 2007 | - | -$15.18M(-62.2%) | -$183.41M(+17.2%) |
| Jun 2007 | - | -$40.14M(+138.1%) | -$156.56M(+49.5%) |
| Mar 2007 | - | -$16.86M(-84.8%) | -$104.75M(+34.2%) |
| Dec 2006 | -$67.74M(+31.0%) | -$111.23M(-1052.9%) | -$78.05M(+94.9%) |
| Sep 2006 | - | $11.67M(0.0%) | -$40.04M(-13.6%) |
| Jun 2006 | - | $11.67M(+18.7%) | -$46.35M(-12.0%) |
| Mar 2006 | - | $9.84M(-113.4%) | -$52.67M(-7.8%) |
| Dec 2005 | -$51.70M | -$73.23M(-1465.9%) | -$57.14M(-455.3%) |
| Sep 2005 | - | $5.36M(0.0%) | $16.08M(+50.0%) |
| Jun 2005 | - | $5.36M(0.0%) | $10.72M(+100.0%) |
| Mar 2005 | - | $5.36M | $5.36M |
FAQ
- What is Jazz Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual EBITDA year-on-year change?
- What is Jazz Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Jazz Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM EBITDA year-on-year change?
What is Jazz Pharmaceuticals annual EBITDA?
The current annual EBITDA of JAZZ is $1.37B
What is the all time high annual EBITDA for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual EBITDA is $1.37B
What is Jazz Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, JAZZ annual EBITDA has changed by +$142.45M (+11.62%)
What is Jazz Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of JAZZ is $98.34M
What is the all time high quarterly EBITDA for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly EBITDA is $424.74M
What is Jazz Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, JAZZ quarterly EBITDA has changed by -$129.55M (-56.85%)
What is Jazz Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of JAZZ is $1.24B
What is the all time high TTM EBITDA for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM EBITDA is $1.37B
What is Jazz Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, JAZZ TTM EBITDA has changed by +$71.61M (+6.13%)